Cargando…

Harnessing the Heterogeneity of Prostate Cancer for Target Discovery Using Patient-Derived Explants

SIMPLE SUMMARY: There is a widespread push toward more biologically relevant pre-clinical models of prostate cancer that can improve the discovery and translation of new drugs and biomarkers for this disease. Patient-derived explant culture is an innovative pre-clinical model that utilizes surgical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Centenera, Margaret M., Vincent, Andrew D., Moldovan, Max, Lin, Hui-Ming, Lynn, David J., Horvath, Lisa G., Butler, Lisa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996971/ https://www.ncbi.nlm.nih.gov/pubmed/35406480 http://dx.doi.org/10.3390/cancers14071708

Ejemplares similares

Evaluation of Small Molecule Drug Uptake in Patient-Derived Prostate Cancer Explants by Mass Spectrometry
por: Mutuku, Shadrack M., et al.
Publicado: (2019)

A patient‐derived explant (PDE) model of hormone‐dependent cancer
por: Centenera, Margaret M., et al.
Publicado: (2018)

Erratum to: IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
por: Carter, Sarah L., et al.
Publicado: (2016)

IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
por: Carter, Sarah Louise, et al.
Publicado: (2016)

GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2′-Deoxycytidine Efficacy in Human Prostate Cancer Cells
por: Chiam, Karen, et al.
Publicado: (2011)

Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
por: Nassar, Zeyad D, et al.
Publicado: (2020)

A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer
por: Shin, Sung-Young, et al.
Publicado: (2023)

Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion
por: Armstrong, Heather K., et al.
Publicado: (2018)

Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)
por: Scheinberg, Tahlia, et al.
Publicado: (2020)

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
por: Gillis, Joanna L, et al.
Publicado: (2021)

Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
por: Hinneh, Josephine A., et al.
Publicado: (2023)

The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities
por: Hinneh, Josephine A., et al.
Publicado: (2022)

Targeting lipid metabolism in metastatic prostate cancer
por: Scheinberg, Tahlia, et al.
Publicado: (2023)

Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
por: Powley, Ian R., et al.
Publicado: (2020)

Harnessing DNA-Based Technology for Drug Discovery
Publicado: (2004)

Harnessing the cyclization strategy for new drug discovery
por: Tang, Kai, et al.
Publicado: (2022)

VERITAS: Harnessing the power of nomenclature in biologic discovery
por: Biswas, Riti, et al.
Publicado: (2023)

Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model
por: Faugeroux, Vincent, et al.
Publicado: (2020)

Harnessing Plant Biodiversity for the Discovery of Novel Anticancer Drugs Targeting Microtubules
por: Xie, Songbo, et al.
Publicado: (2017)

Harnessing heterogeneous nucleation to control tin orientations in electronic interconnections
por: Ma, Z. L., et al.
Publicado: (2017)

Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery
por: de Wet, Timothy J., et al.
Publicado: (2019)

Unravelling Prostate Cancer Heterogeneity Using Spatial Approaches to Lipidomics and Transcriptomics
por: Mutuku, Shadrack M., et al.
Publicado: (2022)

Harnessing the therapeutic vulnerability of MMR heterogeneity in colorectal cancer
por: Anandappa, Gayathri, et al.
Publicado: (2023)

Harnessing heterogeneity in space with statistically guided meta-learning
por: Xie, Yiqun, et al.
Publicado: (2023)

Lineage Tracing of Cardiac Explant Derived Cells
por: Shenje, Lincoln T., et al.
Publicado: (2008)

Har NTNU-studente det for godt?
por: Olstad, Lisa
Publicado: (2006)

Harnessing NKT cells for vaccination
por: Burn, Olivia K, et al.
Publicado: (2021)

Histological and Molecular Evaluation of Patient-Derived Colorectal Cancer Explants
por: Uronis, Joshua M., et al.
Publicado: (2012)

Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer
por: Blagden, Sarah P.
Publicado: (2015)

Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma
por: Pires-Afonso, Yolanda, et al.
Publicado: (2020)

The ethics of explantation
por: Hansson, Sven Ove
Publicado: (2021)

Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
por: Xie, Frank Y., et al.
Publicado: (2006)

Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
por: Gillis, Joanna L., et al.
Publicado: (2013)

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
por: Bruna, Alejandra, et al.
Publicado: (2016)

Harnessing the True Power of Altmetrics to Track Engagement
por: Saud, Sarah, et al.
Publicado: (2021)

Ultrastructural analysis of explanted CyPass microstents and correlation with clinical findings
por: Hübner, Lisa, et al.
Publicado: (2022)

Isolation of human explant derived cardiac stem cells from cryopreserved heart tissue
por: Jackson, Robyn, et al.
Publicado: (2017)

Harnessing the Utility of Ex Vivo Patient Prostate Tissue Slice Cultures
por: Perez, Lillian M., et al.
Publicado: (2022)

Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy
por: Ghosh, Susmita, et al.
Publicado: (2019)

Harnessing Social Media for Substance Use Research and Treatment
por: Crosier, Benjamin S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vi3e39kra8vcu457f200h28d2t